CYPH — Cypherpunk Technologies Share Price
- $81.58m
- $71.89m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 30.27 | ||
| Price to Tang. Book | 30.27 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1932.8% | ||
| Return on Equity | -196.76% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.5 | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cypherpunk Technologies Inc., formerly Leap Therapeutics, Inc., is engaged in developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The Company focuses on the development of sirexatamab and FL-501 to treat patients with cancer. Zcash is a privacy-preserving blockchains, launched as a fork of Bitcoin with advanced cryptography that enables selective transparency. Zcash has introduced privacy technology through the use of zero-knowledge proofs (zk-SNARKs), allowing transactions to be verified without revealing sender, receiver, or amount. FL-501 is a potential class antibody designed to neutralize GDF-15 and prevent the binding to its receptor. sirexatamab (DKN-01), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. Sirexatamab is being developed in patients with esophagogastric, gynecologic, and colorectal cancers.
Directors
- Christopher Mirabelli CHM (66)
- Douglas Onsi PRE (52)
- Augustine Lawlor COO (65)
- Christine Granfield VPR (53)
- Mark O'Mahony OTH (50)
- Cynthia Sirard OTH (51)
- Thomas Dietz LED (57)
- Monica Bertagnolli IND (62)
- James Cavanaugh IND (82)
- William Li IND (58)
- Joseph Loscalzo IND (69)
- Nissim Mashiach IND (60)
- Last Annual
- December 31st, 2024
- Last Interim
- September 30th, 2025
- Incorporated
- January 3rd, 2011
- Public Since
- January 24th, 2017
- No. of Shareholders
- 41
- No. of Employees
- 52
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market
- Shares in Issue
- 56,651,840

- Address
- 47 Thorndike Street, Suite B1-1, CAMBRIDGE, 02142
- Web
- https://www.leaptx.com/
- Phone
- +1 6172524343
- Auditors
- EisnerAmper LLP
Upcoming Events for CYPH
Q4 2025 Cypherpunk Technologies Inc Earnings Release
Q1 2026 Cypherpunk Technologies Inc Earnings Release
Similar to CYPH
ABPRO Holdings
NASDAQ Capital Market
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
Aclarion
NASDAQ Capital Market
FAQ
As of Today at 19:08 UTC, shares in Cypherpunk Technologies are trading at $1.44. This share price information is delayed by 15 minutes.
Shares in Cypherpunk Technologies last closed at $1.44 and the price had moved by -53.99% over the past 365 days. In terms of relative price strength the Cypherpunk Technologies share price has underperformed the S&P500 Index by -59.22% over the past year.
The overall consensus recommendation for Cypherpunk Technologies is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCypherpunk Technologies does not currently pay a dividend.
Cypherpunk Technologies does not currently pay a dividend.
Cypherpunk Technologies does not currently pay a dividend.
To buy shares in Cypherpunk Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.44, shares in Cypherpunk Technologies had a market capitalisation of $81.58m.
Here are the trading details for Cypherpunk Technologies:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: CYPH
Based on an overall assessment of its quality, value and momentum Cypherpunk Technologies is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Cypherpunk Technologies is $3.00. That is 108.33% above the last closing price of $1.44.
Analysts covering Cypherpunk Technologies currently have a consensus Earnings Per Share (EPS) forecast of -$1.11 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cypherpunk Technologies. Over the past six months, its share price has outperformed the S&P500 Index by +210.43%.
As of the last closing price of $1.44, shares in Cypherpunk Technologies were trading +167.39% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cypherpunk Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Cypherpunk Technologies' management team is headed by:
- Christopher Mirabelli - CHM
- Douglas Onsi - PRE
- Augustine Lawlor - COO
- Christine Granfield - VPR
- Mark O'Mahony - OTH
- Cynthia Sirard - OTH
- Thomas Dietz - LED
- Monica Bertagnolli - IND
- James Cavanaugh - IND
- William Li - IND
- Joseph Loscalzo - IND
- Nissim Mashiach - IND





